Misplaced Pages

Ponezumab: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 09:29, 1 November 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: '').← Previous edit Revision as of 09:39, 1 November 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacol...Next edit →
Line 1: Line 1:
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
| verifiedrevid = 450329358 | verifiedrevid = 458433580
| type = mab | type = mab
| image = | image =
Line 25: Line 25:
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 1178862-65-1 | CAS_number = 1178862-65-1
| ATC_prefix = none | ATC_prefix = none
Line 32: Line 32:
| UNII = 1TG15H1XE9 | UNII = 1TG15H1XE9
| PubChem = | PubChem =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = NA | ChemSpiderID = NA
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}

Revision as of 09:39, 1 November 2011

Pharmaceutical compound
Ponezumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
Targetbeta-amyloid
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
UNII
Chemical and physical data
FormulaC6552H10158N1730O2090S52
Molar mass148.3 kDa g·mol
  (what is this?)  (verify)

Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.

Ponezumab was developed by Pfizer Inc.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Ponezumab" (PDF). American Medical Association.
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
Bone
Human
Humanized
Musculoskeletal
Human
Circulatory
Human
Mouse
Chimeric
Humanized
Neurologic
Human
Humanized
Angiogenesis inhibitor
Humanized
Growth factor
Human
Humanized


Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

Categories: